APH vs ARXS: Which Is the Better Buy in 2026?

Last updated September 2026

Short answer

APH is the larger of the two ($201.20B market cap): the incumbent the market prices for continued execution (25.19x forward earnings, beta 1.25). ARXS is the smaller challenger ($22.11B), actually pricier on forward earnings (39.73x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

APH vs ARXS: the tie-breaker metrics

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricAPHARXSWhat it tells you
Market cap$201.20B$22.11BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E25.1939.73Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E40.79641.38Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Price vs 52-week range78% of range64% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book12.984.79How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: APH is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how APH and ARXS affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. APH and ARXS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined APH and ARXS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Amphenol Corporation (APH) do?

Amphenol Corporation designs and manufactures electronic and fiber optic connectors, cable, and interconnect systems used across communications, information technology, automotive, industrial, aerospace, defense, mobile devices, and broadband markets. The business is organized into segments spanning harsh environment solutions, communications solutions, and interconnect and sensor systems, and it grows through a combination of organic design wins and a long, disciplined acquisition history. Its January 2026 completion of the roughly ~$10.5 billion purchase of CommScope's Connectivity and Cable Solutions business meaningfully expanded its fiber optic and IT datacom capabilities.

Full APH guide

What does Arxis (ARXS) do?

Arxis, Inc. designs and manufactures specialized engineered components for demanding, mission-critical applications through two segments, Electronic Components (connectors, cable assemblies, RF and microwave products, sensors, and passives) and Mechanical Components (precision manufacturing). Its end markets split roughly across Defense and Space (around 47 percent of 2025 revenue), Commercial Aerospace (around 23 percent), and Industrial Technology (around 30 percent). The company was founded in 2019 out of predecessor businesses (including Quantic and Qnnect), backed by private-equity firm Arcline Investment Management, and is headquartered in Bloomfield, Connecticut with several thousand employees.

Full ARXS guide

APH vs ARXS: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • APH drivers: AI data center demand; Acquisition-led expansion.
  • ARXS drivers: Defense and space exposure; Margin expansion and profitability swing.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most cited risk is valuation, with the stock trading at a premium price to earnings multiple that assumes continued strong growth. For ARXS, as a company that went public only in April 2026, Arxis has a short trading history and limited public track record, which can drive volatility.

APH or ARXS: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick APH if you believe its drivers more; ARXS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the APH and ARXS guides.

APH vs ARXS: the full fundamentals

APH. As of July 2026 Amphenol had posted record Q1 2026 revenue of roughly ~$7.6 billion, with trailing twelve month revenue near ~$23 billion and EPS around ~$3.66. The premium P/E near ~44x reflects investor expectations for continued AI-driven growth and the added contribution from the CommScope CCS acquisition. These figures are approximate and reference the July 2026 reporting picture.

ARXS. Arxis is profitable and growing quickly, but it trades at a high earnings multiple that reflects strong expectations. Adjusted EBITDA margins near ~38 percent and full-year 2026 adjusted EBITDA guidance of roughly ~$720 to ~$730 million are the metrics the market weighs most. Figures are approximate and reference July 2026.

Headline figures (approximate, July 2026): APH shows revenue (ttm) ~$23 billion, net income (ttm) ~$4.3 billion, diluted eps (ttm) ~$3.66, q1 2026 revenue ~$7.6 billion; ARXS shows revenue (ttm) ~$1.67B, fy2026 revenue guidance ~$1.86B to ~$1.88B, q1 2026 revenue growth ~21% YoY, net income (ttm) ~$104M.

The bottom line: APH vs ARXS

APH and ARXS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined APH and ARXS exposure against your real portfolio. It is not an investment adviser.

Wondering how APH or ARXS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Investing in Amphenol Corporation with AI

Connect the broker you already use and ask Walnut's AI how APH fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

What is the difference between APH and ARXS?

+

Amphenol Corporation designs and manufactures electronic and fiber optic connectors, cable, and interconnect systems used across communications, information technology, automotive, industrial, aerospace, defense, mobile devices, and broadband markets. Arxis, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is APH or ARXS the better stock?

+

Neither is universally better. APH is the larger incumbent; ARXS is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, APH or ARXS?

+

On forward P/E (as of September 2026), APH trades at 25.19x and ARXS at 39.73x, so APH is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both APH and ARXS?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of APH vs ARXS?

+

APH: The most cited risk is valuation, with the stock trading at a premium price to earnings multiple that assumes continued strong growth. A slowdown in AI-related data center capital spending would directly pressure the segment now driving results. Integration risk from large acquisitions like CommScope CCS, including goodwill and added debt, is another concern. Cyclical exposure to automotive, industrial, and mobile markets can create quarter to quarter volatility, and being a global manufacturer leaves it exposed to tariffs, supply chain disruption, and currency swings. Competition from large rivals could pressure pricing and share over time. ARXS: As a company that went public only in April 2026, Arxis has a short trading history and limited public track record, which can drive volatility. The stock carries a premium valuation, with a trailing GAAP price-to-earnings ratio well above the broad market, so any growth or margin disappointment could compress the multiple. Heavy reliance on defense and government-linked spending exposes it to budget cycles, procurement timing, and program delays. Private-equity sponsor ownership means potential future share sales and lock-up expirations could weigh on the stock. Execution risk on acquisitions, supply-chain and input-cost pressures, and customer concentration round out the key concerns.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell APH or ARXS; figures are approximate and dated (as of September 2026). Verify current data before investing.